throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________
`
`EVERGREEN THERAGNOSTICS, INC.
`
`Petitioner
`
`– vs. –
`
`ADVANCED ACCELERATOR APPLICATIONS SA
`
`
`Patent Owner.
`
`____________________
`
`PGR2021-00001
`
`U.S. Patent No. 10,596,278
`
`
`____________________
`
`
`
`EXPLANATION OF MULTIPLE PETITIONS
`CHALLENGING THE SAME PATENT IN ACCORDANCE
`WITH THE JULY 2019 UPDATED PATENT TRIAL GUIDE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`
`
`Petitioner, Evergreen Theragnostics, Inc., respectfully submits this Paper in
`
`support of its Petition for Post Grant Review of all claims (claims 1-25) of U.S.
`
`Patent No. 10,596,278 (“the ’278 patent”). Petitioner has concurrently filed a
`
`petition for Post Grant Review of claims 1-25 of the ’278 patent (PGR2021-00002)
`
`relying on different prior art. Pursuant to the Patent Trial and Appeals Board’s Trial
`
`Practice Guide Update released in July 2019, Petitioner provides this separate paper
`
`to identify the difference between its two petitions and need to file separate petitions
`
`regarding the ’278 patent. Petitioner requests that the Board use its discretion to
`
`institute both petitions.
`
`I.
`
`RANKING OF PETITIONS
`
`Petitioner requests that, if the Board uses its discretion to institute the
`
`Petitions, the Board consider the merits of each petition beginning with this petition
`
`(PGR2021-00001), followed by the petition for PGR2021-00002.
`
`II. THE BOARD SHOULD EXERCISE
`INSTITUTE BOTH PETITIONS
`Petitioner has identified two (2) anticipatory references, i.e., (1) Strosberg
`
`ITS DISCRETION TO
`
`(Ex. 1011) and its accompanying Protocol (Ex. 1012); and (2) Maus (Ex. 1009).
`
`Each Petition relies on one of the anticipatory references as the primary prior art
`
`reference for the unpatentability analysis. This petition relies on Strosberg/Protocol
`
`as the primary prior art reference and PGR2021-00002 relies on Maus as the primary
`
`prior art reference.
`
`
`
`2
`
`

`

`
`
`Because unpatentability is based primarily on either of two anticipatory
`
`references, and considering the word limitations for petitions, it is not possible to
`
`thoroughly and completely address unpatentability using both Strosberg/Protocol
`
`and Maus as primary references.
`
`Moreover, Petitioner has used an expert witness
`
`to establish
`
`that
`
`Strosberg/Protocol was published more than 1 year before the earliest filing date to
`
`which the ’278 patent could claim priority. Therefore, Strosberg/Protocol is prior
`
`art to the ’278 patent under 35 U.S.C. §102(a). The publication date of
`
`Strosberg/Protocol (January 12, 2017), however, is relatively close to the date that
`
`is one year before the ’278 priority date (July 25, 2018), and Petitioner does not
`
`know if Patent Owner will dispute the prior art status of Strosberg/Protocol. If
`
`Petitioner were to file a single petition for Post Grant Review relying on both (1)
`
`Strosberg/Protocol as a primary art reference and (2) Maus as a primary art
`
`reference, and Strosberg/Protocol was later determined to not be prior art, there
`
`would be insufficient space in the petition to thoroughly and completely address
`
`unpatentability on Maus, which is unquestionably prior art. For this reason, the
`
`petitions do not use exactly the same art even with regard to obviousness
`
`combinations. While the Strosberg petition (PGR2021-00001) uses Maus as a
`
`secondary reference regarding some obviousness arguments, the Maus petition
`
`(PGR2021-00002) does not rely on Strosberg/Protocol for unpatentability.
`
`
`
`3
`
`

`

`
`
`Additionally, filing a single petition, relying on both Strosberg/Protocol and
`
`Maus as primary references is further complicated by the number of claims (25) in
`
`the ’278 patent. The larger number of claims precludes being able to provide a
`
`thorough and detailed analysis of why each claim is unpatentable based on both
`
`Strosberg/Protocol as a primary prior art reference and then separately on Maus as a
`
`primary prior art reference.
`
`Finally, where there were issues that needed to be addressed only once (such
`
`as the improper dependency of claim 24), that issue was included only in this petition
`
`(PGR2021-00001).
`
`The differences between the arguments in the two petitions is noted in tabular
`
`format below:
`
`PGR2021-00001
`
`PGR2021-00002
`
`Prior Art Grounds: Claims 1-5, 8-22
`and 24-25 are anticipated by (or would
`have been obvious) over
`Strosberg/Protocol; only obviousness is
`asserted against the other 3 claims
`
`Prior Art Grounds: Claims 1, 8-17 and
`19 are anticipated by (or would have
`been obvious over) Maus; only
`obviousness is asserted against the
`other claims
`
`Obviousness arguments over all claims
`based on Strosberg/Protocol including
`Maus as a secondary reference
`
`Obviousness arguments on all claims
`with various art used as secondary
`reference; Strosberg/Protocol is not
`used as a reference
`
`9 total grounds based on number of
`claims and additional dependent
`limitations
`
`14 total grounds given the different
`primary reference and fewer claims
`asserted to be anticipated
`
`Claim 24 also is invalid for improper
`dependency
`
`Improper dependency argument is not
`included as duplicative of other petition
`
`
`
`4
`
`

`

`
`
`The enumerated Grounds rely on two different anticipatory references as
`
`primary prior art references, necessitating different grounds using different art in the
`
`two petitions. Furthermore, due to the large number of claims, Petitioner required
`
`two petitions to adequately address why the claims of the ’278 patent are
`
`unpatentable. Accordingly, the Board should exercise its discretion to institute both
`
`this Petition and the Petition for PGR2021-00002).
`
`
`
`Dated: October 2, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ C/ Kyle Musgrove
`C. Kyle Musgrove
`Registration No. 40,742
`Attorney for Evergreen Theragnostics, Inc.
`
`
`
`
`
`
`
`5
`
`

`

`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies, in accordance with 37 C.F.R. § 42.6(e), that service
`
`was made on the Patent Owner as detailed below.
`
`Date of service: October 2, 2020
`
`Manner of service: FEDERAL EXPRESS
`
`Documents served: Explanation of Multiple Petitions Challenging the Same
`
`Patent in Accordance with the July 2019 Updated Patent Trial Guide
`
`Persons served: Attorneys of record for U.S. Patent No. 10,596,278, as
`
`follows:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`One Health Plaza 433/2
`East Hanover, NJ 07936
`
`for Biomedical
`
`Institutes
`Novartis
`Research, Inc.
`250 Massachusetts Avenue
`Cambridge, MA 02139
`
`A courtesy copy of the foregoing was also sent by email to: Lian Ouyang,
`
`
`
`
`Novartis Institutes for Biomedical Research, Inc. to: lian.ouyang@novartis.com.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ C/ Kyle Musgrove
`C. Kyle Musgrove
`Registration No. 40,742
`Attorney for Evergreen Theragnostics, Inc.
`
`6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket